Effects of MWM Vs Sustained Mobilization on Knee Osteoarthritis (MWM)

Effects of Mobilization With Movement Versus Sustained Mobilization Along With Eccentric Exercises on Pain & Functional Disability in Patients With Knee Osteoarthritis

This article focused on people diagnosed with grade III Knee OA with sample size of 68 patients , who will randomly divided into two groups . Group A received Mulligan's MWM while group B received Kaltenborn's Sustained Mobilization along with eccentric exercises. The goal of the study was to compare the effectiveness of these two treatment conditions in reducing knee pain and improving joint function decreasing disability in daily activities. The patients followed a structured treatment plan over a set period and outcomes will measured using reliable clinical tools such as NPRS for pain KOOS for functional disability and Goniometer for ROM.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

The word osteoarthritis (OA) is comprised of two separate terms: the prefix "osteo" means bone, and arthritis means joint inflammation. Subcommittee on Osteoarthritis of the American Rheumatism Association, Diagnostic and Therapeutic Criteria Committee, defined OA as "a heterogeneous group of conditions that lead to joint symptoms and signs which are associated with defective integrity of articular cartilage, in addition to related changes in the underlying bone and at the joint margins. "The prevalence of knee pain and symptomatic OA is double in female as compared to male over 20 years. According to a study in people of age 45 or above prevalence of OA is 20% in women and 10% in men. The causes of knee OA include factors such as age, gender, weight, genetics, injuries, and overuse. Common signs and symptoms of knee OA include knee pain, joint stiffness, decreased muscle strength, and proprioceptive deficits. In addition, individuals with knee OA often exhibit poor neuromuscular control, slower walking speed, decreased functional ability, and an increased susceptibility to falling.The most common scale for knee OA classification is the Kellgren-Lawrence (KL) system, which evaluates osteophyte formation, articular cartilage narrowing associated with subchondral bone sclerosis, and altered shape of bone ends from grade 0 to grade 4.

KL classification:

Grade 0: no narrowing; Grade 1: doubtful articular space constriction, osteophytic lipping is possible; Grade 2: permanent osteophytes, potential constriction of the joint space; Grade 3: mild osteophytes, definite constriction of the joint space, and potential end-bone deformation; Grade 4: severe osteophytes, severe constriction of the joint space, severe sclerosis, and definite deformation of the bone.

Radiographes or X-rays to assess pain and restlessness are the foundation for detecting and diagnosing knee OA. Key features that can be observed using X-rays are joint space narrowing, osteophytes, cyst formation, and subchondral sclerosis.The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a wellknown useful diagnostic tool to assess knee ligament injury and osteoarthritis. It includes 42 items in five sub-scales evaluating pain, symptoms, function of daily living, sport and recreation function (sport/rec), and (QOL).The Management of knee OA needs a multidisciplinary approach. The conservative treatment forms for knee OA comprise pharmacological and non-pharmacological modalities. Non-steroidal anti-inflammatory drugs (NSAIDS) are mostly used for pain relief and stiffness caused by OA, with the numerous side effects, particularly on the gastrointestinal tract, making the treatment unsustainable.Manual therapy is a technique used to treat musculoskeletal dysfunctions and pain and usually includes manual therapies, such as massages, joint mobilization, and manipulations. Among the mobilization techniques, Mulligan's mobilization with movement (MWM) has been considered a good alternative for the treatment of musculoskeletal disorders, improving pain and ROM.MWM is based on the concept that minor position faults occur in articulating surfaces of joints following injury or strains, resulting in movement restriction and pain exacerbated by active contraction of muscles within the faulty positions of the joint. Thus, MWM involves passive accessory glide as a corrective technique, applied by the therapist perpendicular to the joint plane to correct the positional fault, combined with the offending movement being performed actively by the subject and sustained for several repetitions. The pain should always be reduced and/or eliminated during the application, and pain-free function should be restored.Sustained mobilisation is a hands-on therapy technique often used in the treatment of knee OA to help reduce pain and improve how well the joint moves. It involves gently holding the joint in a stretched or distracted position for a period of time, which can help loosen stiff tissues, improve joint lubrication, and ease discomfort. For people with knee osteoarthritis-who often experience pain, stiffness, and limited mobility-this type of mobilisation can be a useful way to manage symptoms and support better function. When combined with exercises and other rehabilitation strategies, sustained mobilisation may play a valuable role in improving overall joint health and quality of life.Eccentric exercise actions are characterized by low energy cost, high force production, hypertrophic impact, and a favorable effect on fall risk, physical function, and mobility. Eccentric resistance training may also increase volitional drive and reduce corticospinal inhibition to the muscle more than concentric training in OA. Eccentric actions are essential in daily activities, such as stair descent, squatting, or sitting into a chair.Therefore, this study aims to directly compare MWM and sustained mobilization, each integrated with eccentric strengthening exercises, to determine which approach is more effective for improving pain, range of motion, and functional performance in patients with Grade 3 knee OA. The findings will support physiotherapists in selecting the most appropriate, evidence-based interventions to enhance quality of life and functional independence for individuals living with moderate knee osteoarthritis.

Study Type

Interventional

Enrollment (Estimated)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54600
        • Mayo hospital, Ghurki Trust Teaching Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Age between 45 and 70 years Both male and female patients with a history of knee osteoarthritis were selectedfor this study. Clinically and radiologically diagnosed with Grade III Knee Osteoarthritis (basedon Kellgren and Lawrence scale).

Meets ACR criteria for knee OA

Exclusion Criteria:

History of knee or lower limb surgery Received corticosteroid injections (oral or intra-articular) in the past 6 months Other musculoskeletal conditions in the lower limb(e.g., fracture, bursitis, back pain with radiating symptoms) Diagnosed with inflammatory joint diseases (e.g., rheumatoid arthritis, gout) Neurological conditions affecting lower limbs (e.g., stroke, neuropathy) BMI > 35 (severe obesity) that limits safe participation in exercises Any contraindications to manual therapy (e.g., malignancy, infection, unstablejoint)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mulligan Mobilization
This group will hold intervention for MWM including passive glides while the eccentric exercises includes slow controlled squats
This group will receive total 3 sessions / week (9-12 sessions) Intensity includes Accessory Glide with pain free active knee motion + moderate intensity eccentric loading Type includes Mulligan MWM ( Passive Glide during active knee flexion/extension + Eccentric Quadricpes Exercises (Slow Controlled Squats ) Time 30-45 mins
Other Names:
  • slow controlled squats
Active Comparator: Kaltenborn Mobilization
This arm's intervention includes grade II traction and eccentric loading
This group will receive frequency of 3 session/ week (9-12 sessions) Intensity includes Kaltenborn Grade II Traction according to pain tolerance + Moderate Intensity Eccentric Loading Type of Exercise includes Sustained Joint Mobilization in loose pack position + Quadriceps Exercises (Slow step down ) Time 35-45 mins
Other Names:
  • Eccentric Loading

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Intensity
Time Frame: 4 weeks
The tool used for accessing pain is NPRS. The Numeric Pain Rating Scale (NPRS) is a widely used subjective measure for assessing pain intensity, where participants rate pain on a scale from 0 to 10. A score of 0 indicates no pain, while 10 represents the worst pain imaginable. The NPRS is simple, quick to administer, and highly useful for tracking changes in pain levels over time, evaluating treatment effectiveness, and guiding clinical decision-making. Its reliability and ease of use make it a standard tool in both clinical practice and research settings. Both MWM and Sustained Mobilization aim to reduce pain. The time frame for assessing pain is 4 weeks . While investigator aim to measure at baseline , week 2 and week 4 .
4 weeks
Functional Disability
Time Frame: 4 weeks
The tool used for accessing functional disability is KOOS. The KOOS is a comprehensive, patient-reported outcome measure used to evaluate symptoms, functional limitations, and quality of life in individuals with knee injuries or knee osteoarthritis. It includes five subscales: Pain, Symptoms, Activities of Daily Living (ADL), Sport and Recreation Function, and Knee-related Quality of Life. Each item is scored on a 5-point Likert scale and then converted to a 0-100 scale, where 0 represents extreme knee problems and 100 indicates no knee problems. Each subscale is scored independently, allowing clinicians and researchers to assess specific domains of knee function and monitor changes over time. The KOOS is valued for its sensitivity to both short-term and long-term functional outcomes. While invesyigator aim to measure at baseline , week 2 and week 4 .
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ROM
Time Frame: 4 weeks
The tool used for accessing ROM is Goniometer. A goniometer is a standard clinical tool used to measure the range of motion (ROM) in patients with knee osteoarthritis. It provides an objective assessment of joint mobility by measuring angles during knee flexion and extension. The stationary arm is aligned with the femur, the movable arm with the tibia, and the axis is positioned over the lateral epicondyle of the femur. ROM values help identify functional limitations, monitor disease progression, and evaluate the effectiveness of therapeutic interventions. Accurate goniometric measurement is essential for documenting baseline impairments and tracking improvements throughout rehabilitation.The time frame for assessing pain is 4 weeks . While investigator aim to measure at baseline , week 2 and week 4 .
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 30, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

December 8, 2025

First Submitted That Met QC Criteria

December 23, 2025

First Posted (Estimated)

January 2, 2026

Study Record Updates

Last Update Posted (Estimated)

January 2, 2026

Last Update Submitted That Met QC Criteria

December 23, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on mulligan moblization

Subscribe